Management
Srinivasa Nagalla, MD
PRESIDENT AND CHIEF EXECUTIVE OFFICERDr. Nagalla is the principal founder and chief executive officer of Diabetomics. He was previously founder and CEO of ProteoGenix, Inc., a successful innovator in maternal-fetal health diagnostics, which was acquired by Hologic, Inc. (HOLX) in 2010. Before founding ProteoGenix, Dr. Nagalla was Associate Professor of Pediatrics at Oregon Health & Science University. He is the lead inventor on several key patents on biomarkers for clinical diagnostics, and has previously served on National Institutes of Health-sponsored national consortiums on biotechnology, genomics, and proteomics. Dr. Nagalla has over 25 years of broad, multi-disciplinary experience in clinical medicine, biotechnology, and commercialization. Dr. Nagalla received his MD from the All-India Institute of Medical Sciences in New Delhi, and post-doctoral training at Harvard University and Oregon Health & Science University.
Barbara Chiapuzio
CHIEF FINANCIAL OFFICERMs. Chiapuzio brings over 20 years of experience growing privately-held entrepreneurial environments in a range of industries including technology, software-as-a-service and manufacturing. Prior to joining Diabetomics, Ms. Chiapuzio served as chief financial officer of Smarsh, a software-as-a-service company providing archiving and compliance solutions, and as chief financial officer of Network Elements, a manufacturer of optical modules. She was vice president of finance at Claremont Technology Group, an IT consulting firm, where she played a leading role in the company’s IPO process. She began her career in public accounting at KPMG. Ms. Chiapuzio holds a BS in Business Administration with a concentration in Accounting from Portland State University.
Paturi V. Rao, MD, PhD, FRCP
VICE PRESIDENT AND CHIEF MEDICAL OFFICERDr. Rao is co-founder and director for Diabetomics operations in India and Asia. Dr. Rao was previously Professor and Chief of Endocrinology at Nizam’s Institute of Medical Sciences University in Hyderabad, India, and established the Research Society for the Study of Diabetes in India (RSSDI) and served as Secretary from 1993-2007. RSSDI is the largest diabetes care providers’ organization in Asia, with more than 7000 member diabetologists. Dr. Rao has served as principal investigator on several key international clinical studies in diabetes, including ORIGIN, DREAM, and several phase-II and phase-III clinical trials for Novo Nordisk, Eli Lilly, Aventis, Merck Sharp & Dohme, Novartis, and Johnson & Johnson. Dr. Rao serves on the advisory committees of the Indian Council of Medical Research, the Department of Science & Technology, and several pharmaceutical companies.
Charles Roberts, PhD
VICE PRESIDENT AND CHIEF SCIENCE OFFICERDr. Roberts is co-founder and chief science officer since 2008. Dr. Roberts is a molecular endocrinologist with over 30 years of experience in diabetes research, is an internationally recognized expert on insulin action, and has authored over 250 scientific papers and review articles. Dr. Roberts is also a co-inventor on various patents on therapeutics and biomarkers for clinical diagnostics, and serves on numerous review panels for the National Institutes of Health and the editorial boards of several major biomedical research journals. From 1984-1994, he was a Senior Investigator in the Diabetes Branch of the National Institutes of Health, and subsequently Professor and Associate Chair for Research in the Department of Pediatrics and Professor of Medicine at Oregon Health & Science University.
Steven Kazmierczak, PhD, DABCC
VICE PRESIDENT AND CLINICAL LABORATORY DIRECTORDr. Kazmierczak joined Diabetomics in 2010 and serves as the director of CLIA laboratory operations. He has over 20 years of experience in laboratory medicine. He is board-certified in chemical pathology, and has interests in the development, evaluation, and clinical application of diagnostic laboratory test systems. He serves as Director of the Scientific Advisory Board for ABAXIS Corp., Gamma Therapeutics, and Albumetix. Dr. Kazmierczak is also on the editorial board of several journals specializing in laboratory medicine, is Associate Editor of Clinical Chemistry and Laboratory Medicine, and serves on numerous national committees for the AACC, ASCP, and CAP.
Sumeet Roy, BS, MBA, PhD
VICE PRESIDENT AND MANAGER OF DIABETOMICS MEDICALDr. Roy is Vice President and Manager of Diabetomics Medical (P), Ltd. – the Indian manufacturing plant of Diabetomics, Inc. He brings over 20 years of experience in the healthcare industry. Prior to joining Diabetomics, Dr. Roy served as the chief executive officer of Kamineni Life Sciences, a leading manufacturer of Invitro Diagnostic Reagents in India. He has extensive experience in clinical research administration and worked for three years in clinical research administration at the Dept. of Psychiatry, University of South Florida in Tampa. He serves as a qualified quality assessor of Clinical Trial Sites, Ethics Committees and Investigators for National Accreditation Board for Hospitals and Healthcare Providers (NABH) in India. Dr. Roy holds a Masters in Business Administration and PhD in Management.